EPrC-009

N/A

Report date: 2025/04/28 10:12:58
NME

Base Information

Drug NameEPrC-009
Drug Alias NameEPrC-009
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptor alpha degradersProtein kinase C beta modulators
TargetsEstrogen receptor alphaProtein kinase C beta
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A